NCT03469661View on ClinicalTrials.gov

Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS)

CompletedOBSERVATIONAL
Enrollment

63

Participants

Timeline

Start Date

April 25, 2018

Primary Completion Date

April 19, 2021

Study Completion Date

April 19, 2021

Conditions
Immune ThrombocytopeniaMyelodysplastic Syndromes
Trial Locations (6)

Unknown

Complejo Hospitalario de A Coruña, A Coruña

Hospital de Burgos, Burgos

Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria

Hospital Ramon y Cajal, Madrid

Hospital Regional de Málaga, Málaga

Hospital Virgen de la Victoria, Málaga

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Fundacion CRIS de Investigación para Vencer el Cáncer

OTHER

NCT03469661 - Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) | Biotech Hunter | Biotech Hunter